{
    "Trade/Device Name(s)": [
        "\u03b1-Gliatest IgA",
        "\u03b1-Gliatest IgG",
        "\u03b1-GliaPep IgA",
        "\u03b1-GliaPep IgG"
    ],
    "Submitter Information": "Grifols USA, LLC",
    "510(k) Number": "K113377",
    "Predicate Device Reference 510(k) Number(s)": [
        "K052439"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "MST"
    ],
    "Summary Letter Date": "December 14, 2012",
    "Summary Letter Received Date": "November 28, 2012",
    "Submission Date": "November 27, 2012",
    "Regulation Number(s)": [
        "21 CFR 866.5750"
    ],
    "Regulation Name(s)": [
        "Radioallergosorbent (RAST) immunological test system"
    ],
    "Analyte Class(es)": [
        "immunology",
        "autoimmune"
    ],
    "Analyte(s)": [
        "IgA antibodies against gliadin",
        "IgG antibodies against gliadin",
        "IgA antibodies against deamidated gliadin peptide",
        "IgG antibodies against deamidated gliadin peptide"
    ],
    "Specimen Type(s)": [
        "Serum"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "ELISA (Enzyme-Linked Immunosorbent Assay)"
    ],
    "Methodologies": [
        "Enzyme immunoassay"
    ],
    "Submission Type(s)": [
        "Assay",
        "Kit",
        "Calibrator",
        "Control"
    ],
    "Document Summary": "FDA 510(k) summary for Grifols \u03b1-Gliatest and \u03b1-GliaPep ELISA assays for detection of anti-gliadin and anti-deamidated gliadin peptide antibodies in serum to aid in celiac disease diagnosis",
    "Indications for Use Summary": "Semi-quantitative determination of IgA or IgG antibodies against gliadin or deamidated gliadin peptide in human serum, as an aid in the diagnosis of celiac disease, used in conjunction with other serological tests and clinical findings.",
    "fda_folder": "Immunology"
}